![Intravenous (IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?]()
Intravenous (IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?Gozzetti, Alessandro; Candi, Veronica; Zuanelli Brambilla, Corrado; Papini, Giulia; Bocchia, Monica · British Journal of Haematology · 2016